The International Research Conference, taking place on September 12-13, 2024, in New York, United States, stands as a noteworthy initiative by a federated organization. Tailored to encompass diverse scholarly events with variable durations, this conference ensures quality content delivery, offering substantial value to students, academics, and industry researchers. The International Conference on Sustainability in Hospitals and Healthcare serves as a gathering point for leading academic scientists, researchers, and scholars. This premier interdisciplinary platform facilitates the exchange of experiences and research findings, encouraging discussions on recent innovations, trends, challenges, and practical solutions in the vital realm of Sustainability in Hospitals and Healthcare, contributing to global advancements.

Read on waset.org

The International Conference on Recent Developments in Clinical Healthcare Technologies, slated for September 12-13, 2024, in Rome, Italy, is organized by a federated organization dedicated to hosting diverse scholarly events. Recognized for its high quality, this conference offers exceptional value to students, academics, and industry researchers. Its primary objective is to convene leading academic scientists, researchers, and scholars to exchange experiences and research findings on all aspects of Recent Developments in Clinical Healthcare Technologies. Moreover, it serves as a premier interdisciplinary platform for discussing recent innovations, trends, concerns, practical challenges, and adopted solutions in this field, fostering collaboration among researchers, practitioners, and educators to advance clinical healthcare technologies.

Read on waset.org

The International Conference on Medicine, slated for September 12-13, 2024, in New York, United States, will be conducted digitally under the umbrella of the International Research Conference. This event, organized by a federated organization, aims to convene a diverse array of scholarly events, offering exceptional value to students, academics, and industry researchers. With a focus on all facets of medicine, the conference provides a unique platform for leading academic scientists, researchers, and scholars to exchange insights and share their latest research findings. Additionally, it facilitates interdisciplinary discussions among practitioners, educators, and researchers to address current innovations, trends, and challenges in the medical field.

Read on waset.org

The International Conference on Biopharmaceutical Development and Drug Manufacturing, scheduled for September 12-13, 2024, in New York, United States, will take place in a digital format. Organized by the International Research Conference, this event aims to assemble prominent academic scientists, researchers, and scholars to exchange insights and present research findings in Biopharmaceutical Development and Drug Manufacturing. It offers a valuable platform for interdisciplinary discussions on recent innovations, trends, and challenges in these fields. Participants will benefit from engaging with a diverse range of perspectives and gaining practical knowledge from experts in academia and industry. The conference promises to deliver exceptional value to students, academics, and industry professionals alike.

Read on waset.org

The Ambulatory Care 2024 CNE Conference is set for Thursday, September 12, 2024, from 7:00 am to 6:00 pm in the Central time zone. Designed for RNs, LPNs, MAs, and Social Workers in ambulatory care settings, including primary care and subspecialties, the conference covers diverse topics such as immunizations, behavioral health, artificial intelligence, and nurse wellbeing. Attendees will explore advances in technology, ambulatory initiatives like workplace violence prevention, and strategies to enhance nurse wellbeing. With options for both in-person and livestream attendance, this conference caters to healthcare professionals in all ambulatory and primary care settings, fostering continued professional development and knowledge exchange.

 [Read on ce.mayo.edu](https://ce.mayo.edu/nursing/content/ambulatory-care-2024-cne-conference#group-tabs-node-course-default1)

PReS - 2024, set to unfold in Gothenburg, Sweden, from September 11th to 14th, promises an enriching experience in pediatric rheumatology. Renowned clinicians and scientists will convene to present and discuss cutting-edge developments in pathophysiology, diagnostics, and clinical management. Attendees can anticipate engaging sessions such as Grand Debates and Thieves Market, alongside a plethora of outstanding presentations covering diverse themes. The program also features traditional highlights like the Young Investigators Meeting and the EULAR Pediatric Ultrasound Course. Beyond the conference, participants can immerse themselves in Gothenburg's maritime heritage, indulge in fresh seafood, and explore vibrant neighborhoods, all conveniently located within walking distance of the venue.

 [Read on pres.eu/pres2024](https://www.pres.eu/pres2024/registration.html)

Pre-Filled Syringes Connect is sheduled on 11 -12 September 2024 in Boston, USA.As a new addition to SAE's leading injectable drug delivery portfolio, PFS Connect will bring together thought leaders from big pharma, biotech, and device developers in an intimate, relaxed, and engaging setting. This event will foster collaborations and idea exchanges crucial for driving innovation in injectable drug delivery.Pre-Filled Syringes Connect is sheduled on  The two-day agenda will feature a series of roundtable discussions facilitated by industry experts sharing their invaluable expertise and experiences. These discussions will address industry challenges and emerging trends, equipping you with actionable knowledge to enhance your device development initiatives and strategic approach. Keynote presentations will provide insights into the latest case studies and innovations in the field.

 [Read on www.smgconferences.com](https://www.smgconferences.com/pharmaceuticals/northamerica/conference/pfsamericas-connect/booknow)

The Pharmacovigilance & Drug Safety Conference 2024 aims to equip participants with strategies to optimize pharmacovigilance and risk management amidst an evolving drug safety landscape. Amid advancing medical science, vigilance in monitoring drug safety is paramount. With growing complexities in therapies and regulatory scrutiny, pharmacovigilance gains significance. Effective systems are vital to mitigate adverse drug reactions, particularly as global medication consumption rises. Collaboration among regulatory bodies, healthcare providers, and patients is crucial to identify risks and enhance patient safety. By fostering international cooperation and knowledge sharing, the conference endeavors to bolster drug safety and pharmacovigilance on a global scale. 

[Read on corvusglobalevents.com](https://corvusglobalevents.com/pharmacovigilance-world/products)

Join us in Edinburgh, Scotland, UK, from September 11-13, 2024, for the 8th World Congress on Controversies in Breast Cancer (CoBrCa). This renowned event is dedicated to addressing pressing and disputed issues that clinicians encounter in their daily practice, seeking to unravel unresolved clinical and therapeutic dilemmas. Distinguished experts from various disciplines worldwide will engage in debates, discussions, and deliver lectures spanning medical oncology, surgery, breast imaging, radiation oncology, pathology, reconstruction, and more. After each presentation, ample time will be allocated for participants to actively participate in discussions, fostering a collaborative exchange of insights and knowledge. Don't miss this opportunity to stay at the forefront of breast cancer care.

Read on cobrca.org

The 5th Optimizing Hybrid Clinical Trials Summit 2024 convenes stakeholders in Clinical Operations, Innovation, Procurement, and Digital Health to address challenges in conducting successful hybrid trials. Key topics include building budget and financial business cases, ensuring end-to-end data flow, and maintaining data integrity. Participants will gain practical insights on financial strategies, data quality enhancement through electronic capture, and leveraging digital solutions to reduce patient burden. This event, attended by senior stakeholders from leading pharmaceutical companies like Pfizer, Bayer, Eli Lilly and Co, among others, aims to optimize hybrid clinical trials, enhance diversity, equity, and inclusion (DE&I), and improve operational efficiency. 

[Read on optimizing-hybrid-clinical-trials](https://optimizing-hybrid-clinical-trials.com/take-part/register/)